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Clinics and pathology 
Disease 
Non Hodgkin lymphoma. 
Phenotype/cell stem origin 
One case to date, a 65-year-old female patient with a 
follicular lymphoma stage II-a (Impera et al., 2008). 
Evolution 
Complete remission was obtained. 
Cytogenetics 
Additional anomalies 
A complex karyotype was found, with +11, and other 
anomalies. 





AFF3 belongs to a family of putative transcription 
factors also comprising AFF1 (AF4, FEL, MLLT2) in 
4q21, AFF2 (FMR2, FRAXE) in Xq28 and AFF4 
(AF5Q31) in 5q31. AFF3 has been found a 
susceptibility gene in autoimmune diseases, namely 
rheumatoid arthritis, psoriatic arthritis, and juvenile 
idiopathic arthritis (Barton et al., 2009; Castelino and 
Barton, 2010; Hinks et al., 2010). AFF3 is deleted in 
Nievergelt syndrome, an autosomal dominant 
mesomelic dysplasia (Steichen-Gersdorf et al., 2008). 
AFF3 was also found expressed in 20% of mammary 











Fusion of AFF3 exon 1 to BCL2 exon 2. 
Fusion protein 
Oncogenesis 
Leads to the overexpression of BCL2. 
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